"The U.S. Food and Drug Administration today approved Vimizim (elosulfase alfa), the first FDA-approved treatment for Mucopolysaccharidosis Type IVA (Morquio A syndrome). Morquio A syndrome is a rare, autosomal recessive lysosomal storage disease "...
Valstar Patient Information including How Should I Take
In this Article
- What is valrubicin (Valstar)?
- What are the possible side effects of valrubicin (Valstar)?
- What is the most important information I should know about valrubicin (Valstar)?
- Who should not use valrubicin (Valstar)?
- How should I use valrubicin (Valstar)?
- What happens if I miss a dose (Valstar)?
- What happens if I overdose (Valstar)?
- What should I avoid while using valrubicin (Valstar)?
- What other drugs will affect valrubicin (Valstar)?
- Where can I get more information?
Who should not use valrubicin (Valstar)?
Do not use valrubicin without first talking to your doctor if you have
- a urinary tract infection;
- a perforated or otherwise damaged bladder;
- kidney disease; or
- irritable bladder disorder.
The use of valrubicin may be dangerous if you have any of the conditions listed above.
Valrubicin is in the FDA pregnancy category C. Systemic exposure to valrubicin may result in harm to an unborn baby. Do not use valrubicin without first talking to your doctor if you are pregnant. Men and women being treated with valrubicin should discuss with their doctor the appropriate use of birth control during treatment with valrubicin if necessary.
Because of the potential for serious side effects in a nursing infant, breast-feeding should be avoided during treatment with valrubicin.
The safety and effectiveness of valrubicin in children has not been established.
How should I use valrubicin (Valstar)?
Valrubicin should only be administered under the supervision of a qualified healthcare provider experienced in the use of cancer chemotherapeutic agents.
Your doctor will determine the correct amount and frequency of treatment with valrubicin depending upon the type of cancer being treated and other factors. Valrubicin has caused a complete response in only about 1 in 5 patients and delaying surgery could lead to wide-spread bladder cancer, which is lethal. Talk to your doctor if you have any questions or concerns regarding the treatment schedule.
Your doctor will probably want you to have regularly scheduled blood tests and other medical evaluations during treatment with valrubicin to monitor progress and side effects.
Skin accidentally exposed to valrubicin should be rinsed thoroughly with soap and warm water.
Your healthcare provider will store valrubicin as directed by the manufacturer. If you are storing valrubicin at home, follow the directions provided by your healthcare provider.
Additional Valstar Information
Valstar - User Reviews
Valstar User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.